These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 18285354

  • 1. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes.
    Nah SS, Choi IY, Lee CK, Oh JS, Kim YG, Moon HB, Yoo B.
    Rheumatology (Oxford); 2008 Apr; 47(4):425-31. PubMed ID: 18285354
    [Abstract] [Full Text] [Related]

  • 2. Phase 2 enzyme inducer sulphoraphane blocks prostaglandin and nitric oxide synthesis in human articular chondrocytes and inhibits cartilage matrix degradation.
    Kim HA, Yeo Y, Jung HA, Jung YO, Park SJ, Kim SJ.
    Rheumatology (Oxford); 2012 Jun; 51(6):1006-16. PubMed ID: 22332123
    [Abstract] [Full Text] [Related]

  • 3. Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2α, p38-MAPK and NF-κB in advanced glycation end products stimulated human chondrocytes.
    Rasheed Z, Haqqi TM.
    Biochim Biophys Acta; 2012 Dec; 1823(12):2179-89. PubMed ID: 22982228
    [Abstract] [Full Text] [Related]

  • 4. Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes.
    Mathy-Hartert M, Deby-Dupont GP, Reginster JY, Ayache N, Pujol JP, Henrotin YE.
    Osteoarthritis Cartilage; 2002 Jul; 10(7):547-55. PubMed ID: 12127835
    [Abstract] [Full Text] [Related]

  • 5. Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes.
    Li X, Afif H, Cheng S, Martel-Pelletier J, Pelletier JP, Ranger P, Fahmi H.
    J Rheumatol; 2005 May; 32(5):887-95. PubMed ID: 15868626
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. COX-2 and iNOS are critical in advanced glycation end product-activated chondrocytes in vitro.
    Huang CY, Hung LF, Liang CC, Ho LJ.
    Eur J Clin Invest; 2009 May; 39(5):417-28. PubMed ID: 19371268
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes.
    Chabane N, Zayed N, Afif H, Mfuna-Endam L, Benderdour M, Boileau C, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.
    Osteoarthritis Cartilage; 2008 Oct; 16(10):1267-74. PubMed ID: 18417374
    [Abstract] [Full Text] [Related]

  • 10. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes.
    Rasheed Z, Akhtar N, Haqqi TM.
    Rheumatology (Oxford); 2011 May; 50(5):838-51. PubMed ID: 21172926
    [Abstract] [Full Text] [Related]

  • 11. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
    Alvarez-Soria MA, Herrero-Beaumont G, Moreno-Rubio J, Calvo E, Santillana J, Egido J, Largo R.
    Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
    [Abstract] [Full Text] [Related]

  • 12. Glucosamine sulfate reduces prostaglandin E(2) production in osteoarthritic chondrocytes through inhibition of microsomal PGE synthase-1.
    Kapoor M, Mineau F, Fahmi H, Pelletier JP, Martel-Pelletier J.
    J Rheumatol; 2012 Mar; 39(3):635-44. PubMed ID: 22089456
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypoxia-inducible factor 1alpha is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes.
    Grimmer C, Pfander D, Swoboda B, Aigner T, Mueller L, Hennig FF, Gelse K.
    Arthritis Rheum; 2007 Dec; 56(12):4084-94. PubMed ID: 18050215
    [Abstract] [Full Text] [Related]

  • 17. The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes.
    Guillén MI, Megías J, Clérigues V, Gomar F, Alcaraz MJ.
    Rheumatology (Oxford); 2008 Sep; 47(9):1323-8. PubMed ID: 18621749
    [Abstract] [Full Text] [Related]

  • 18. Mori folium inhibits interleukin-1β-induced expression of matrix metalloproteinases and inflammatory mediators by suppressing the activation of NF-κB and p38 MAPK in SW1353 human chondrocytes.
    Jeong JW, Lee HH, Lee KW, Kim KY, Kim SG, Hong SH, Kim GY, Park C, Kim HK, Choi YW, Choi YH.
    Int J Mol Med; 2016 Feb; 37(2):452-60. PubMed ID: 26707272
    [Abstract] [Full Text] [Related]

  • 19. Sclareol exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model.
    Zhong Y, Huang Y, Santoso MB, Wu LD.
    Int J Clin Exp Pathol; 2015 Feb; 8(3):2365-74. PubMed ID: 26045743
    [Abstract] [Full Text] [Related]

  • 20. Endothelin-1 in osteoarthritic chondrocytes triggers nitric oxide production and upregulates collagenase production.
    Manacu CA, Martel-Pelletier J, Roy-Beaudry M, Pelletier JP, Fernandes JC, Shipkolye FS, Mitrovic DR, Moldovan F.
    Arthritis Res Ther; 2005 Feb; 7(2):R324-32. PubMed ID: 15743480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.